Research and Markets: Non-Small Cell Lung Cancer - Pipeline Review, H1 2015

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/hzbrpb/nonsmall_cell) has announced the addition of the "Non-Small Cell Lung Cancer - Pipeline Review, H1 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Non-Small Cell Lung Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Non-Small Cell Lung Cancer and special features on late-stage and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from the proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by the team. Drug profiles/records featured in the report undergoes periodic updates following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

Companies Mentioned

Partial list of the 200+ companies mentioned in this comprehensive report:

  • AB Science
  • Bayer AG
  • Benitec Biopharma
  • Calithera Biosciences
  • Daiichi Sankyo
  • Eagle Pharmaceuticals
  • F. Hoffmann-La Roche
  • Five Prime Therapeutics
  • GeneFrontier
  • Halozyme Therapeutics
  • HanAll Biopharma
  • Ignyta
  • Immune Design
  • Jeil Pharmaceutical
  • Jiangsu Hengrui Medicine
  • Kadmon
  • KAEL-GemVax
  • Mabion
  • MacroGenics
  • NanoCarrier
  • Natco Pharma
  • Omnitura Therapeutics
  • Oncobiologics
  • Panacea Biotec
  • Peregrine Pharmaceuticals
  • Qu Biologics
  • Reata Pharmaceuticals
  • Samyang
  • Sanofi
  • Taiho Pharmaceutical
  • Targovax
  • Ultimovacs
  • XBiotech USA
  • Zhejiang BetaPharma

For more information, including full list of companies mentioned, please visit http://www.researchandmarkets.com/research/hzbrpb/nonsmall_cell

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology